These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26963698)

  • 1. Cardiac complications in thalassemia major.
    Auger D; Pennell DJ
    Ann N Y Acad Sci; 2016 Mar; 1368(1):56-64. PubMed ID: 26963698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.
    Pennell DJ; Udelson JE; Arai AE; Bozkurt B; Cohen AR; Galanello R; Hoffman TM; Kiernan MS; Lerakis S; Piga A; Porter JB; Walker JM; Wood J;
    Circulation; 2013 Jul; 128(3):281-308. PubMed ID: 23775258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study.
    Casale M; Meloni A; Filosa A; Cuccia L; Caruso V; Palazzi G; Gamberini MR; Pitrolo L; Putti MC; D'Ascola DG; Casini T; Quarta A; Maggio A; Neri MG; Positano V; Salvatori C; Toia P; Valeri G; Midiri M; Pepe A
    Circ Cardiovasc Imaging; 2015 Aug; 8(8):e003230. PubMed ID: 26253625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
    Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Roughton M; Assomull R; Nair SV; Walker JM; Pennell DJ
    Circulation; 2007 Apr; 115(14):1876-84. PubMed ID: 17372174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.
    Chaosuwannakit N; Makarawate P; Wanitpongpun C
    Tomography; 2021 Apr; 7(2):130-138. PubMed ID: 33919601
    [No Abstract]   [Full Text] [Related]  

  • 6. Effective iron chelation practice for patients with β-thalassemia major.
    Carson SM; Martin MB
    Clin J Oncol Nurs; 2014 Feb; 18(1):102-11. PubMed ID: 24476732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular MRI in thalassemia major.
    Wood JC; Noetzli L
    Ann N Y Acad Sci; 2010 Aug; 1202():173-9. PubMed ID: 20712790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients.
    Cassinerio E; Roghi A; Pedrotti P; Brevi F; Zanaboni L; Graziadei G; Pattoneri P; Milazzo A; Cappellini MD
    Ann Hematol; 2012 Sep; 91(9):1443-9. PubMed ID: 22572843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study.
    Ambati SR; Randolph RE; Mennitt K; Kleinert DA; Weinsaft JW; Giardina PJ
    Am J Hematol; 2013 Aug; 88(8):652-6. PubMed ID: 23640778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients.
    El Beshlawy A; El Tagui M; Hamdy M; El Ghamrawy M; Azim KA; Salem D; Said F; Samir A; St Pierre T; Pennell DJ
    Ann Hematol; 2014 Mar; 93(3):375-9. PubMed ID: 23949317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of global strain values of myocardium in beta-thalassemia major patients with iron load using specific feature tracking in cardiac magnetic resonance imaging.
    Rezaeian N; Mohtasham MA; Khaleel AJ; Parnianfard N; Kasani K; Golshan R
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1343-1349. PubMed ID: 32346846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National networking in rare diseases and reduction of cardiac burden in thalassemia major.
    Pepe A; Pistoia L; Gamberini MR; Cuccia L; Lisi R; Cecinati V; Maggio A; Sorrentino F; Filosa A; Rosso R; Messina G; Missere M; Righi R; Renne S; Vallone A; Dalmiani S; Positano V; Midiri M; Meloni A
    Eur Heart J; 2022 Jul; 43(26):2482-2492. PubMed ID: 34907420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
    Maggio A; Vitrano A; Capra M; Cuccia L; Gagliardotto F; Filosa A; Magnano C; Rizzo M; Caruso V; Gerardi C; Argento C; Campisi S; Cantella F; Commendatore F; D'Ascola DG; Fidone C; Ciancio A; Galati MC; Giuffrida G; Cingari R; Giugno G; Lombardo T; Prossomariti L; Malizia R; Meo A; Roccamo G; Romeo MA; Violi P; Cianciulli P; Rigano P
    Blood Cells Mol Dis; 2009; 42(3):247-51. PubMed ID: 19233692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective combination therapy of deferiprone and deferoxamine for the rapid clearance of excess cardiac IRON and the prevention of heart disease in thalassemia. The Protocol of the International Committee on Oral Chelators.
    Kolnagou A; Kontoghiorghes GJ
    Hemoglobin; 2006; 30(2):239-49. PubMed ID: 16798649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis.
    Koohi F; Kazemi T; Miri-Moghaddam E
    Ann Hematol; 2019 Jun; 98(6):1323-1331. PubMed ID: 30729283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalassemia.
    Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach.
    Pepe A; Meloni A; Rossi G; Midiri M; Missere M; Valeri G; Sorrentino F; D'Ascola DG; Spasiano A; Filosa A; Cuccia L; Dello Iacono N; Forni G; Caruso V; Maggio A; Pitrolo L; Peluso A; De Marchi D; Positano V; Wood JC
    Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):299-309. PubMed ID: 28200076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major.
    Meloni A; Restaino G; Borsellino Z; Caruso V; Spasiano A; Zuccarelli A; Valeri G; Toia P; Salvatori C; Positano V; Midiri M; Pepe A
    Int J Cardiol; 2014 Dec; 177(3):1012-9. PubMed ID: 25449516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal analysis of heart and liver iron in thalassemia major patients according to chelation treatment.
    Danjou F; Origa R; Anni F; Saba L; Cossa S; Podda G; Galanello R
    Blood Cells Mol Dis; 2013 Oct; 51(3):142-5. PubMed ID: 23816436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International survey of T2* cardiovascular magnetic resonance in β-thalassemia major.
    Carpenter JP; Roughton M; Pennell DJ;
    Haematologica; 2013 Sep; 98(9):1368-74. PubMed ID: 23812939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.